Overall rank by patents
#30,455
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 7 technology areas, active 2019–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
The verdict
United holds 9 US patents across 7 technology areas, rank #30,455 of 50,000 tracked assignees.
United Animal Health, Inc. has been granted 9 US utility patents between 2019 and 2025, placing United Animal Health, Inc. at rank #30,455 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.2 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a US Corporation, United Animal Health, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, United sits between UENO FINE Chemicals Industry, Ltd. (9 patents, rank #30,451) and Universidad DE Buenos Aires (9 patents, rank #30,459) - the closest US assignees by grant volume. The composite Innovation Score of 37.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 1 in the 2015–2019 window, a +700% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. United Animal Health, Inc.'s 15.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark United Animal Health, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
UENO FINE CHEMICALS INDUSTRY, LTD.
9 patents
ULC TECHNOLOGIES
9 patents
ULTRALOGIC 5G, LLC
9 patents
UNIONPLACE CO., LTD.
9 patents
UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
9 patents
UNITED TEST AND ASSEMBLY CENTER LTD.
9 patents
UNITED WIRE, LTD
9 patents
UNIVERSIDAD DE BUENOS AIRES
9 patents
UNITED ANIMAL HEALTH, INC.
9 patents
What this shows United holds 9 patents at rank #30,455, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #30,455 in granted patent volume.
Other assignees with the most granted patents in United's primary technology class.
United's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
38 Top 43% higher than 57% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 11.1% |
| 2020 | 1 | 11.1% |
| 2021 | 1 | 11.1% |
| 2022 | 1 | 11.1% |
| 2023 | 1 | 11.1% |
| 2024 | 3 | 33.3% |
| 2025 | 1 | 11.1% |
Top 7 of 7 technology areas
Overall rank by patents
#30,455
Across all tracked assignees
37.5 out of 100
How to use this portfolio
United's 9 grants land it in the top 43% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.